Advanced cancer patients understanding and perceptions of phase i clinical trials

Jamie Pawlowski, Laeeq Malik, Devalingam Mahalingam

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

This questionnaire-based study assessed the understanding and perceptions of cancer patients who were participating in a Phase I clinical trial at baseline and determined any changes after enrollment. Thirty-six patients participated. Less than one-third of respondents (28.5%) thought the purpose of Phase I trials was dose escalation for safety and efficacy. Patients anticipated varying degree of therapeutic benefit ranging from stable disease (47.1%) to complete shrinkage of the tumor (32.4%). No change in measured themes was observed. Patients participating in Phase I trials need further education to improve their understanding of the true intent of early Phase trials.

Original languageEnglish (US)
Pages (from-to)490-495
Number of pages6
JournalCancer Investigation
Volume33
Issue number10
DOIs
StatePublished - Nov 26 2015

Keywords

  • Chemotherapy
  • Clinical trials
  • Medical ethics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Advanced cancer patients understanding and perceptions of phase i clinical trials'. Together they form a unique fingerprint.

  • Cite this